Pilar Garrido Lopez (P Garrido, Pilar Garrido)

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 24

Top Venues

Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Clinical cancer research : an official journal of the American Association for Cancer Research

Future oncology (London, England)

This page only lists publications with an associated author ORCID identifier.

Publications

Ana Gómez Rueda, Álvaro Taus, Rosa Álvarez Álvarez, Reyes Bernabé-Caro, Luis Chara, Marta López-Brea, Laia Vilà, Maria Ángeles Sala González, Anabel Del Barrio Díaz Aldagalán, Beatriz Esteban Herrera, Rafael López Castro, Ruth Álvarez Cabellos, Marta Doménech, Sandra Falagan, Alberto Moreno Vega, Carlos Aguado, Andrés Barba, Maria Teresa Delgado Ureña, Dolores Isla, Lorena Bellido Hernández, José Luis Fírvida Pérez, Óscar Juan-Vidal, Bartomeu Massutí, Xabier Mielgo-Rubio, Ana Laura Ortega, Silvia Catot, Manuel Dómine, Corina Escoín-Pérez, Francisco García Navalón, Ignacio Gil-Bazo, Silvia Muñoz, Delvys Rodríguez-Abreu, Rosa María Villatoro Roldán, Guillermo Alonso-Jáudenes Curbera, Luis León-Mateos, Airam Padilla, Alfredo Paredes Lario, José Miguel Sánchez-Torres, Pilar Garrido Lopez, null null
The S-REAL study: Spanish real-world data on unresectable stage III NSCLC patients treated with durvalumab after chemoradiotherapy. Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico 26 (7) (2024)
Ana Gómez Rueda, Álvaro Taus, Rosa Álvarez Álvarez, Reyes Bernabé-Caro, Luis Chara, Marta López-Brea, Laia Vilà, Maria Ángeles Sala González, Anabel Del Barrio Díaz Aldagalán, Beatriz Esteban Herrera, Rafael López Castro, Ruth Álvarez Cabellos, Marta Doménech, Sandra Falagan, Alberto Moreno Vega, Carlos Aguado, Andrés Barba, Maria Teresa Delgado Ureña, Dolores Isla, Lorena Bellido Hernández, José Luis Fírvida Pérez, Óscar Juan-Vidal, Bartomeu Massutí, Xabier Mielgo-Rubio, Ana Laura Ortega, Silvia Catot, Manuel Dómine, Corina Escoín-Pérez, Francisco García Navalón, Ignacio Gil-Bazo, Silvia Muñoz, Delvys Rodríguez-Abreu, Rosa María Villatoro Roldán, Guillermo Alonso-Jáudenes Curbera, Luis León-Mateos, Airam Padilla, Alfredo Paredes Lario, José Miguel Sánchez-Torres, Pilar Garrido Lopez, null null
The S-REAL study: Spanish real-world data on unresectable stage III NSCLC patients treated with durvalumab after chemoradiotherapy. Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico (2024)
Ana Gómez Rueda, Álvaro Taus, Rosa Álvarez Álvarez, Reyes Bernabé-Caro, Luis Chara, Marta López-Brea, Laia Vilà, Maria Ángeles Sala González, Anabel Del Barrio Díaz Aldagalán, Beatriz Esteban Herrera, Rafael López Castro, Ruth Álvarez Cabellos, Marta Doménech, Sandra Falagan, Alberto Moreno Vega, Carlos Aguado, Andrés Barba, Maria Teresa Delgado Ureña, Dolores Isla, Lorena Bellido Hernández, José Luis Fírvida Pérez, Óscar Juan-Vidal, Bartomeu Massutí, Xabier Mielgo-Rubio, Ana Laura Ortega, Silvia Catot, Manuel Dómine, Corina Escoín-Pérez, Francisco García Navalón, Ignacio Gil-Bazo, Silvia Muñoz, Delvys Rodríguez-Abreu, Rosa María Villatoro Roldán, Guillermo Alonso-Jáudenes Curbera, Luis León-Mateos, Airam Padilla, Alfredo Paredes Lario, José Miguel Sánchez-Torres, Pilar Garrido Lopez, null null
The S-REAL study: Spanish real-world data on unresectable stage III NSCLC patients treated with durvalumab after chemoradiotherapy. Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico 26 (7) (2024)
Ana Gómez Rueda, Álvaro Taus, Rosa Álvarez Álvarez, Reyes Bernabé-Caro, Luis Chara, Marta López-Brea, Laia Vilà, Maria Ángeles Sala González, Anabel Del Barrio Díaz Aldagalán, Beatriz Esteban Herrera, Rafael López Castro, Ruth Álvarez Cabellos, Marta Doménech, Sandra Falagan, Alberto Moreno Vega, Carlos Aguado, Andrés Barba, Maria Teresa Delgado Ureña, Dolores Isla, Lorena Bellido Hernández, José Luis Fírvida Pérez, Óscar Juan-Vidal, Bartomeu Massutí, Xabier Mielgo-Rubio, Ana Laura Ortega, Silvia Catot, Manuel Dómine, Corina Escoín-Pérez, Francisco García Navalón, Ignacio Gil-Bazo, Silvia Muñoz, Delvys Rodríguez-Abreu, Rosa María Villatoro Roldán, Guillermo Alonso-Jáudenes Curbera, Luis León-Mateos, Airam Padilla, Alfredo Paredes Lario, José Miguel Sánchez-Torres, Pilar Garrido Lopez, null null
The S-REAL study: Spanish real-world data on unresectable stage III NSCLC patients treated with durvalumab after chemoradiotherapy. Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico 26 (7) (2024)
Jordi Remon, Benjamin Besse, Santiago Ponce Aix, Ana Callejo, Kamal Al-Rabi, Reyes Bernabe, Laurent Greillier, Margarita Majem, Noemí Reguart, Isabelle Monnet, Sophie Cousin, Pilar Garrido Lopez, Gilles Robinet, Rosario Garcia Campelo, Anne Madroszyk, Julien Mazieres, Hubert Curcio, Bartosz Wasag, Yassin Pretzenbacher, Fanny Grillet, Anne-Marie C Dingemans, Rafal Dziadziuszko
Overall Survival From the EORTC LCG-1613 APPLE Trial of Osimertinib Versus Gefitinib Followed by Osimertinib in Advanced EGFR -Mutant Non-Small-Cell Lung Cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (12) (2024)
Jordi Remon, Benjamin Besse, Santiago Ponce Aix, Ana Callejo, Kamal Al-Rabi, Reyes Bernabe, Laurent Greillier, Margarita Majem, Noemí Reguart, Isabelle Monnet, Sophie Cousin, Pilar Garrido Lopez, Gilles Robinet, Rosario Garcia Campelo, Anne Madroszyk, Julien Mazieres, Hubert Curcio, Bartosz Wasag, Yassin Pretzenbacher, Fanny Grillet, Anne-Marie C Dingemans, Rafal Dziadziuszko
Overall Survival From the EORTC LCG-1613 APPLE Trial of Osimertinib Versus Gefitinib Followed by Osimertinib in Advanced EGFR -Mutant Non-Small-Cell Lung Cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2024)
Jordi Remon, Benjamin Besse, Santiago Ponce Aix, Ana Callejo, Kamal Al-Rabi, Reyes Bernabe, Laurent Greillier, Margarita Majem, Noemí Reguart, Isabelle Monnet, Sophie Cousin, Pilar Garrido Lopez, Gilles Robinet, Rosario Garcia Campelo, Anne Madroszyk, Julien Mazieres, Hubert Curcio, Bartosz Wasag, Yassin Pretzenbacher, Fanny Grillet, Anne-Marie C Dingemans, Rafal Dziadziuszko
Overall Survival From the EORTC LCG-1613 APPLE Trial of Osimertinib Versus Gefitinib Followed by Osimertinib in Advanced EGFR -Mutant Non-Small-Cell Lung Cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (12) (2024)
Jordi Remon, Benjamin Besse, Santiago Ponce Aix, Ana Callejo, Kamal Al-Rabi, Reyes Bernabe, Laurent Greillier, Margarita Majem, Noemí Reguart, Isabelle Monnet, Sophie Cousin, Pilar Garrido Lopez, Gilles Robinet, Rosario Garcia Campelo, Anne Madroszyk, Julien Mazieres, Hubert Curcio, Bartosz Wasag, Yassin Pretzenbacher, Fanny Grillet, Anne-Marie C Dingemans, Rafal Dziadziuszko
Overall Survival From the EORTC LCG-163 APPLE Trial of Osimertinib Versus Gefitinib Followed by Osimertinib in Advanced EGFR -Mutant Non-Small-Cell Lung Cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2024)
Petros Christopoulos, Nicolas Girard, Claudia Proto, Marta Soares, Pilar Garrido Lopez, Anthonie J van der Wekken, Sanjay Popat, Joris Diels, Claudio A Schioppa, Jan Sermon, Nora Rahhali, Corinna Pick-Lauer, Agnieszka Adamczyk, James Penton, Marie Wislez
Amivantamab Compared with Real-World Physician's Choice after Platinum-Based Therapy from a Pan-European Chart Review of Patients with Lung Cancer and Activating EGFR Exon 20 Insertion Mutations. Cancers 15 (22) (2023)
Vivek Subbiah, Philippe A Cassier, Salvatore Siena, Elena Garralda, Luis Paz-Ares, Pilar Garrido Lopez, Ernest Nadal, Jacqueline Vuky, Gilberto Lopes, Gregory P Kalemkerian, Daniel W Bowles, Mahesh Seetharam, Jianhua Chang, Hui Zhang, Jennifer Green, Alena Zalutskaya, Martin Schuler, Yun Fan, Curigliano Giuseppe
Pan-cancer efficacy of pralsetinib in patients with RET fusion-positive solid tumors from the phase 1/2 ARROW trial. Nature medicine 28 (8) (2022)
Laura Q M Chow, Fabrice Barlesi, Erin M Bertino, Martin J Van Den Bent, Heather A Wakelee, Patrick Y Wen, Chao-Hua Chiu, Sergey Orlov, Rita Chiari, Margarita Majem Tarruella, Mark McKeage, Chong-Jen Yu, Pilar Garrido Lopez, Felipe K Hurtado, Pilar Cazorla Arratia, Yuanbo Song, Fabrice Branle, Michael Shi, Dong Wan Kim
ASCEND-7: Efficacy and Safety of Ceritinib Treatment in Patients with ALK-Positive Non-Small Cell Lung Cancer Metastatic to the Brain and/or Leptomeninges. Clinical cancer research : an official journal of the American Association for Cancer Research 28 (12) (2022)
Jay M Lee, Masahiro Tsuboi, Edward S Kim, Tony S K Mok, Pilar Garrido Lopez
Overcoming immunosuppression and pro-tumor inflammation in lung cancer with combined IL-1β and PD-1 inhibition. Future oncology (London, England) 18 (27) (2022)
Keunchil Park, Eric B Haura, Natasha B Leighl, Paul Mitchell, Catherine A Shu, Nicolas Girard, Santiago Viteri, Ji-Youn Han, Sang-We Kim, Chee Khoon Lee, Joshua K Sabari, Alexander I Spira, Tsung-Ying Yang, Dong Wan Kim, Ki Hyeong Lee, Rachel E Sanborn, José Trigo, Koichi Goto, Jong-Seok Lee, James Chih-Hsin Yang, Ramaswamy Govindan, Joshua M Bauml, Pilar Garrido Lopez, Matthew G Krebs, Karen L Reckamp, John Xie, Joshua C Curtin, Nahor Haddish-Berhane, Amy Roshak, Dawn Millington, Patricia Lorenzini, Meena Thayu, Roland E Knoblauch, Byoung Chul Cho
Amivantamab in EGFR Exon 20 Insertion-Mutated Non-Small-Cell Lung Cancer Progressing on Platinum Chemotherapy: Initial Results From the CHRYSALIS Phase I Study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 39 (30) (2021)
Víctor Albarrán Fernández, Javier Pozas, Juan José Soto Castillo, Jorge Esteban, Elena Corral de la Fuente, Yolanda Lage Alfranca, Pablo Gajate, Pilar Garrido Lopez
Management of Intracranial Metastases in EGFR-Mutated NSCLC: A Review of Literature following an Unusual Case Report. Case reports in oncological medicine 2021 (2021)
Pilar Garrido Lopez, Janice Tsang, Solange Peters
Gender gap: surveying the world for tomorrow. ESMO open 5 (4) (2021)
Pilar Garrido Lopez, Luis Paz-Ares, Margarita Majem, Teresa Morán, José Manuel Trigo, Joaquim Bosch-Barrera, Rosario Garcίa-Campelo, José Luis González-Larriba, José Miguel Sánchez-Torres, Dolores Isla, Núria Viñolas, Carlos Camps, Amelia Insa, Óscar Juan, Bartomeu Massuti, Alfredo Paredes, Ángel Artal, Marta López-Brea, José Palacios, Enriqueta Felip
LungBEAM: A prospective multicenter study to monitor stage IV NSCLC patients with EGFR mutations using BEAMing technology. Cancer medicine 10 (17) (2021)
Pilar Garrido Lopez, R Hladun, E de Álava, R Álvarez, F Bautista, F López-Ríos, R Colomer, F Rojo
Multidisciplinary consensus on optimising the detection of NTRK gene alterations in tumours. Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico 23 (8) (2021)
Pilar Garrido Lopez, Jean-Louis Pujol, Edward S Kim, Jay M Lee, Masahiro Tsuboi, Ana Gómez-Rueda, Amparo Benito, Nicolas Moreno, Luis Gorospe, Tuochuan Dong, Cecile Blin, Vanessa Rodrik-Outmezguine, Vanessa Q Passos, Tony S K Mok
Canakinumab with and without pembrolizumab in patients with resectable non-small-cell lung cancer: CANOPY-N study design. Future oncology (London, England) 17 (12) (2021)
Helena A Yu, Luis G Paz-Ares, James Chih-Hsin Yang, Ki Hyeong Lee, Pilar Garrido Lopez, Keunchil Park, Joo-Hang Kim, Huzhang Mao, Sameera R Wijayawardana, Ling Gao, Rebecca R Hozak, Bo H Chao, David Planchard
Phase I Study of the Efficacy and Safety of Ramucirumab in Combination with Osimertinib in Advanced T790M-positive EGFR-mutant Non-small Cell Lung Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research 27 (4) (2020)
Javier Molina-Cerrillo, Teresa Alonso-Gordoa, Pilar Garrido Lopez
Tumor-associated macrophages: "Good cop-bad cop". Cancer 125 (11) (2019)
Dolores Isla, Javier De Castro Carpeño, R García-Campelo, Pilar Lianes, Enriqueta Felip Font, Pilar Garrido Lopez, Luis G Paz-Ares, J M Trigo
Treatment options beyond immunotherapy in patients with wild-type lung adenocarcinoma: a Delphi consensus. Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico 22 (5) (2019)
Pilar Garrido Lopez, E Conde, J de Castro, J J Gómez-Román, E Felip, L Pijuan, D Isla, J Sanz, L Paz-Ares, F López-Ríos
Updated guidelines for predictive biomarker testing in advanced non-small-cell lung cancer: a National Consensus of the Spanish Society of Pathology and the Spanish Society of Medical Oncology. Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico 22 (7) (2019)
Edward S Kim, Karen Kelly, Luis G Paz-Ares, Pilar Garrido Lopez, Shadia Jalal, Daruka Mahadevan, Martin Gutierrez, Mariano Provencio, Eric Schaefer, Monte Shaheen, Erica L Johnston, P Kellie Turner, Siva Rama Prasad Kambhampati, Richard Beckmann, Anwar Hossain, William J John, Jonathan W Goldman
Abemaciclib in Combination with Single-Agent Options in Patients with Stage IV Non-Small Cell Lung Cancer: A Phase Ib Study. Clinical cancer research : an official journal of the American Association for Cancer Research 24 (22) (2018)
Solange Peters, Rolf Stahel, Lukas Bubendorf, Philip Bonomi, Augusto Villegas, Dariusz M Kowalski, Christina S Baik, Dolores Isla, Javier De Castro Carpeno, Pilar Garrido Lopez, Achim Rittmeyer, Marcello Tiseo, Christoph Meyenberg, Sanne de Haas, Lisa H Lam, Michael W Lu, Thomas E Stinchcombe
Trastuzumab Emtansine (T-DM1) in Patients with Previously Treated HER2-Overexpressing Metastatic Non-Small Cell Lung Cancer: Efficacy, Safety, and Biomarkers. Clinical cancer research : an official journal of the American Association for Cancer Research 25 (1) (2018)

Pilar Garrido Lopez.css-eqlu8i{font-size:small;padding-left:4px;} (P Garrido, Pilar Garrido)

Publication Activity (10 Years)

Top Topics

Top Venues

Pilar Garrido Lopez (P Garrido, Pilar Garrido)